docGlobal Fabry Disease Market
download 
Report Transcription
Global Fabry Disease Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 – 2026 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com Report Description Report Description Fabry disease is also known as Anderson-Fabry disease and alpha-galactosidase A deficiency. It is a rare genetic disorder of lipid metabolism resulting from the deficient activity of the alphagalactosidase A (a-Gal A) enzyme. The deficiency of the enzyme is caused by the alterations in the genes that instructs the cells to make alpha-galactosidase A (a-Gal A) enzyme. Fabry disease is known to cause variety of systemic symptoms and complications, one of them being metabolic disorders. The metabolism of sphingolipids is minimized, in fabry disease which results in the multiple organ failure and death. Owing to the deficiency of alpha galactosidase A enzyme, glycolipid called Gb3 accumulates in the blood vessels and other organs and thus results in formation of blockage or clots that leads to malfunctioning of the system. Fabry Disease Market: Drivers and Restraints The major drivers that drive the fabry disease market growth are extensive R&D activities, adoption of advanced technologies in the research practices. Due to hereditary nature and severity of the disease, complications in physiological systems, such as cardiac system, urinary system and others are expected to increase the demand for trustworthy treatment. Extensive R&D practices is one of the valuable drivers of the market. Due to this, various therapeutic products, such as, PRX-102, JR-051, NP-003, GC-1119 and others, are under pipeline studies. However, rare incidence rate (1 in 40,000), lack of awareness about advancements in genetic sciences, technological limitations in certain region of the world are some of the restraining factors that may affect the growth of the fabry disease market. Report Description Report Description Fabry Disease Market: Segmentation The global fabry disease market has been classified on the basis of treatment, end use and geography. Based on treatment, the global fabry disease market is divided into following: • Enzyme replacement therapy • Gene therapy • Pharmaceutical formulations containing agalsidase alpha • Analgesics • Anticonvulsants • NSAIDs Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb1365 Based on end user type, the global fabry disease market is divided into following: • Hospitals • Clinics Fabry Disease Market: Overview The enzyme replacement therapy is designed to provide enzyme to the patients suffering from enzyme deficiency. It was found that this treatment was not a complete cure though it improved Report Description Report Description the metabolism. Enzyme replacement therapy is the most expensive and unaffordable treatment among the treatments for fabry disease, hence the market for enzyme replacement therapy is expected to register moderate growth in overall fabry disease market. The analgesics, anticonvulsants and NSAIDs are generally known for the treatment of pain and other symptoms associated with fabry disease hence, contributing majorly to the market. Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1365 Fabry Disease Market: Regional Overview Geographically, the global fabry disease market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa. North America is estimated to be the most lucrative region owing to the affordability of the treatment followed by Europe. The rare incidences in APAC and MEA countries are expected to limit the growth of fabry disease market in these regions. Fabry Disease Market: Key Players The major players operating in this market and involved in development of new medications include Sanofi-Aventis LLC, iBio, Inc., GlaxoSmithKline plc, Genzyme Corporation, and Neuraltus Pharmaceuticals, Inc. Some of the existing key players in the global fabry disease market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Amgen Inc., Teva pharmaceutical Industries Ltd., Pfizer Inc., Takeda Pharmaceutical Co. Ltd. Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Healthcare, Pharmaceuticals & Medical Devices Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Hari. T (Sr. Manager - Global Business Development) Email: hari.t@futuremarketinsights.com Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705
Similar documents
Diagnosed Prevalent Cases of Fabry Disease in The 7MM Will Rise at an AGR of 7.71% By 2024
The report,” Fabry Disease - Epidemiology Forecast to 2024 “provides an overview of the risk factors, comorbidities/manifestations, and the global and historical epidemiological trends for Fabry disease in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK and Japan). It also includes a 10-year epidemiological forecast for the diagnosed prevalent cases of Fabry disease in these markets, segmented by age and sex.
Global Mobile Tracking Solution Market
Mobile tracking solution enables user to get real time update on the position of mobile assets. GPS devices and RFID tags when attached with equipment and assets ensure efficient mobile tracking. Handheld scanners and mobile phones can also be used to track mobile assets. Mobile traction solution find their application in medical asset tracking, mobile industrial generator tracking, construction assets tracking, military assets tracking, wild-life and conservation, and shipping & container tracking etc.
Global Business Email Market
Electronic mail solution or preferably called email solution, specializes in the day-to-day management of your email services which allows users to remain focused on more critical operations of business. Email solution providers make it simple for organizations and enterprises to communicate across as well as get tasks implemented by offering a reliable, business suited email software to meet such needs. The business email solution offers multiple layers of premium virus and spam protection and keep hosted email advertisement free. Business organizations across the globe are now steadily adopting the strategy of migrating their email to cloud to reduce costs. The enumeration of organizations migrating to cloud-based email and collaboration services has continued to build over the past few years, where previously small and medium business (SMB) were the key end-users of business email solutions, now larger organizations are aggressively moving to the cloud. The current number of email users worldwide in 2015 is recognized to be about 2.6 billion, and this figure is expected to grow at a healthy CAGR till 2026. While total worldwide email traffic estimated to about 200 billion email per day in 2015, the corporate emails represent the major share of this total value.
Global Content Delivery Network (CDN) Market
A content delivery network is an interconnected distributed system of proxy or cache servers deployed across numerous data centers that use geographical vicinity of the user as a benchmark for delivering web content. The goal of a content delivery network is to allow effective functioning of internet by serving content to end-users with zero latency and high performance. Rapidly ballooning base of internet users has played a huge role in transforming the market of content delivery network service provision. Content delivery networks serve a majority of the internet content today, comprising of downloadable objects like media files and software, web objects like text, graphics and scripts, live streaming media, on-demand streaming media, and social networks.
Polysorbate-80 Market Size, Analysis, and Forecast Report: 2016-2026
Polysorbate-80 (PS80), also known as “tween 80” is a fatty acid esters of polyoxyethylene sorbitan. PS80 consist of a heterogeneous chemical structure distribution. PS80s are commonly used as non-ionic surfactants in the formulation of bio therapeutic products to prevent surface adsorption and stabilize protein against aggregation induced by stresses such as agitation and shear. It is widely used in food preparation, pharmaceuticals, and personal care and beauty products, such as cold creams, baby lotions, bath oils, and suntan lotions.
CHPTAC Market Dynamics, Forecast, Analysis and Supply Demand 2016-2026
CHPTAC is an abbreviation of 3-chloro-2-hydroxypropyltrimethyl ammonium chloride. Chemically CHPTAC is known as Liquid Cationic Etherification Agent with a molecular formula C6H15Cl2NO. CHPTAC has a molecular weight of 188.10.
Zwieback Market Value Share, Supply Demand, share and Value Chain 2016-2026
Zwieback is the type of sweetened bread or rusk that include eggs. Zwieback includes ingredients such as flour, sugar, soybean oil, yeast and butter and nutrients such as carbohydrates, fat and protein. Zwieback can be consumed in combination with other food products such as fruits and coffee. Zwieback is considered as healthy food option especially for infants. Zwieback is used for teething babies. Zwieback is also used by old aged consumers as it is easy to digest and considered to be healthy option.
Global Operating Room Equipment Market
Operating room is a facility where all the surgical procedures are performed on patients in order to treat different physiological and pathological conditions in a sterile environment, operating rooms are also known as the operation theatre or operating suite. An operating room equipped with technically advanced equipment ensures better patient care and enhanced operational efficiency by empowering surgeons and other healthcare professionals with greater flexibility and ease of handling. All these equipment are used for the betterment of patient care and enhanced operational efficiency by empowering surgeons and other healthcare professionals with greater flexibility and ease of handling.
Lead Market Revenue, Opportunity, Forecast and Value Chain 2014 - 2020
Lead is a soft and malleable metal belonging to the carbon group. It is the heaviest non-radioactive element which occurs naturally on earth in the form of four isotopes: lead-208, 207, 206, and 204. It is generally found in ores with copper, silver and zinc and is extracted together with these metals. Lead compounds exist in two main oxidation states: +4 and +2. It is widely used in construction activities, production of weights, lead-acid batteries, and as a radiation shield. Conventional lead-acid batteries have a significant history in providing energy storage for a wide range of end-use applications, in mobile as well as stationary applications.